Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The stock is ready to pop
Is there anyone out there that actually believes that this product won't get FDA approval in 2017?
From your DD when do you think it will be approved?
This is the stock of the year... It was a blessing as a stock buyer when the CRL was issued...time to go shopping at near 18/share. thank you very much FDA... Nobody else has NEJM published data or another Xa reversal agent in the works so since the need is so hi the FDA will approve... I suspect someone is interesed in buying PTLA and now is primetime since round 1 is over.
Time to stock up on PTLA... I would say the odds on this one beats BJ in Vego.
I am buying as much as I can...
Its not whether its when...
Never been so sure...
Management better not mess up here - their reputation is on the line now with that unexpected CRL everyone was not hoping for. Eyes on
PTLA receives CRL for AndexXA: #msg-124608836.
It's not clear about the delay. Will buy some short puts today on any pop
$PTLA Someone at the company knew something and sold off after 2pm - wouldn't surprise me if SEC nabs them for insider trading in a year. Based on my experience, a heavily touted drug as the one everyone was seeking being delayed could lead to a 40% cut today
i bought a call, seems optimistic, but who knows with the fad
I bought a call on this, so I am optimistic, but who really knows what the FDA will decide.
Only jumped 8 cents a couple days before decision day - maybe because there is not much controversy...will see what happens today...the stock will be halted tmrw, won't it - until decision is made...didn't end up buying any shares, but interesting to watch. Good Luck to All!
From what I am hearing, Andexanet alfa will be approved next week.
Just a matter of how much of a bounce we see.
52 week Range: $18.20 to $57.96.
Yep, I'm here :)
PTLA is almost 5% of my portfolio with the nice run today. I'm really feeling good about increasing my position today. I like TGTX better, but this one is top ten in my book.
Well - they must have bought quite a few shares. Good points....thinking of getting in on this stock - just came a cross it today....anyone out there?
I love the play on PTLA here!
https://biotechinvesting.info/2016/08/04/bought-ptla/
BETTER OFF WITH YOUR CYDY
Biotech Movers and Shakers: Portola Pharmaceuticals and United Therapeutics Corporation
http://marketexclusive.com/biotech-movers-and-shakers-portola-pharmaceuticals-inc-nasdaqptla-and-united-therapeutics-corporation
You sir have one more follower! Enjoy the weekend!
Thanks again!!! Very glad I asked you!
You nailed this. Nicely done. Did you short via puts? I sold long ago but I have always kept an eye on PTLA. Thanks for the "DD" over the years DD.
Good decision (eom).
Betrixaban fails APEX study: #msg-121427861.
Thank you, much appreciated. I might hold off on buying a this time.
Please see #msg-110608087 and #msg-105048954. Regards, Dew
Might be wiser to buy call options you think if I have to bet?
What are your thoughts on why end points might not be met?
I don’t think the Betrixaban APEX study will hit its primary endpoint.
Gotcha.
I'm thinking of going long with a small number of shares. Lots of institutional ownership and a MC already north of a billion makes me feel good about this stock. So far I've only played microcaps with small tute ownership and small trials. Feel better about making a bet on this one.
Planning to play it both ways.
Thanks. How do you feel about the upcoming data early next month?
Fda decision is in August.
Correction: Just P3 data, not FDA decision
Anybody home? New to the stock. Seems like FDA decision on pivotal P3 trial is expected in April. How do people think about the chances of success with the FDA?
Dew. Same pattern today. I think someone put a April 40-60 bull call spread of about 500 options.
Any luck looking into it ?
Last year on the 30 th of August. Some one got about 1 k of sept 50 calls and then in the next week or so make about 400-600k.
Something similar happening in the last few weeks lots of calls being traded and this time their conf call is Friday am instead of pm....
I haven't paid any attention to option volumes. What are you trying to say?
Dew. I have something for you to think about.
Have u see the call options volume recently in ptla?
PDUFA date for Andexanet Alfa is 8/17/16: #msg-120596413.
PTLA-BMY/PFE ink Andexanet Alfa commercialization deal for Japanese market:
#msg-120219801
PTLA completes BLA submission for Andexanet Alfa: #msg-119267088.
PTLA raises ~$162M at $48.00/sh: #msg-118931731.
PTLA selling 2.99M* shares at unspecified price: #msg-118918347.
As you probably know, Pradaxa is not a Factor Xa inhibitor, so it can't be reversed by Annexa A. However, the availability of a Pradaxa-reversal agent from B-I is a small matter for PTLA in the overall scheme of things.
European Ad Comm backs Boehringer Ingelheim's anticoagulant reversal agent
http://www.seekingalpha.com/news/2797866
PTLA reports final phase-3 data on Annexa-A* in Xarelto reversal:
#msg-116997511
PTLA upsized the phase-3 trial of Betrixaban from 6850 to 7500 patients to maintain the desired statistical power. (Source: 2Q15 CC.)
Followers
|
22
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
196
|
Created
|
05/22/13
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |